+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Oral antidiabetic agents: what are the choices?

Revue Medicale de la Suisse Romande 111(8): 701-705

Oral antidiabetic agents: what are the choices?

Accession: 040874533

PMID: 1925244

Related references

Rybka, J.; Kvapil, M., 2002: New oral antidiabetic agents and current strategies of peroral antidiabetic therapy (PAD). Optimal compensation in patients with type 2 diabetes is individualization of therapy according to the stage of the disease and ratio of the main pathophysiological disorders. Because of the hitherto inadequate effectiveness of known procedures at...

Cavallo Perin, P.; Fornengo, P., 2012: New oral antidiabetic agents. The pathophysiology of hyperglycemia in type 2 diabetes (T2DM) involves 3 main defects: insulin deficiency, excess hepatic glucose output, and insulin resistance. Oral anti-diabetic agents act in a variety of ways. These include agents that stimul...

Bierman, E.L., 1976: The oral antidiabetic agents. Oral antidiabetic agents can be used to lower blood glucose levels in some adult-onset diabetics who do not have acute complications and in whom control of hyperglycemia by weight reduction alone or insulin treatment is not possible. Except for th...

Krzentowski, G., 1988: Oral antidiabetic agents, yes but.... Revue Medicale de Bruxelles 9(3): 144-147

Vonesch, H.J., 1988: Oral antidiabetic agents. Schweizerische Rundschau für Medizin Praxis 77(9): 210-212

Alvarez Guisasola, F., 2011: Update on the latest family of oral drugs marketed for the treatment of type 2 diabetes: DPP-4 inhibitors. Contributions with respect to other families of oral antidiabetic agents. The recent introduction of new drugs in the therapeutic arsenal for the management of hyperglycemia in type 2 diabetes has opened up new perspectives and raised hope for improved metabolic control in these patients. DPP-4 inhibitors are a family o...

Gamble, J.; Simpson, S.H.; Brown, L.C.; Johnson, J.A., 2008: Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis. Although evidence-based guidelines for the treatment of type 2 diabetes mellitus provide clear recommendations for initial therapy, evidence on an optimal treatment strategy after secondary failure is unclear. To compare the efficacy of add-on the...

Lebovitz, H.E., 2004: Oral antidiabetic agents: 2004. The appropriate management of patients with type 2 diabetes presents many challenges to health care providers. The first several years of type 2 diabetes are likely to be unrecognized and untreated. The pathophysiology of type 2 diabetes dictates...

Everett, J.A., 1998: Use of oral antidiabetic agents during breastfeeding. Journal of Human Lactation 13(4): 319-321

Anonymous, 1968: Overuse of oral antidiabetic agents. Discontinuing unnecessary drug treatment is discussed.